Peninsula cell therapy company's CEO resigns as FDA raises manufacturing questions
May 19, 2021 at 17:54 PM EDT
The company is building manufacturing in Philadelphia for its experimental metastatic melanoma treatment, which it hopes to file for FDA approval next year.
